ONCORESPONSE, INC

Profile

Company Names

ONCORESPONSE, INC
ONCORESPONSE INC

Addresses

609 MAIN STREET, SUITE 4200, HOUSTON, TX 77002

909 FANNIN STREET, SUITE 2100, HOUSTON, TX 77010

1124 COLUMBIA STREET, SUITE 300, SEATTLE, WA 98104

Phone Numbers

(206) 805-1600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$109,039,285.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-04-21 
$5,999,138.00 
INDEFINITE 
INDEFINITE 
Equity 
4
2023-05-01 
$13,915,153.00 
$40,000,000.00 
$26,084,847.00 
Equity 
3
2021-03-17 
$40,625,995.00 
$60,000,000.00 
$19,374,005.00 
Equity 
2
2018-08-23 
$18,999,999.00 
$39,999,995.00 
$20,999,996.00 
Equity 
1
2015-09-30 
$29,499,000.00 
$34,044,454.00 
$4,545,454.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALICE 
 
BEXON 
EXECUTIVE OFFICER
ROBERTO 
 
DE PONTI 
DIRECTOR
ROBERTO 
 
DEPONTI 
DIRECTOR
ALAN 
 
GINSBERG 
DIRECTOR
RUSS 
 
HAWKINSON 
EXECUTIVE OFFICER
PATRICK 
JOSEPH 
HOJLO 
DIRECTOR
NATHAN 
 
JORGENSEN 
DIRECTOR
TED 
 
KOUTOUZIS 
DIRECTOR
BOB 
 
LECHLEIDER 
EXECUTIVE OFFICER
ROBERT 
J. 
LECHLEIDER 
EXECUTIVE OFFICER
SEAN 
 
MCCARTHY 
DIRECTOR
SEAN 
A. 
MCCARTHY 
DIRECTOR
KAMAL 
 
PURI 
EXECUTIVE OFFICER
KAMAL 
D. 
PURI 
EXECUTIVE OFFICER
CHRIS 
 
RUSSELL 
EXECUTIVE OFFICER
CHRISTOPHER 
A. 
RUSSELL 
EXECUTIVE OFFICER
CLIFFORD 
 
STOCKS 
EXECUTIVE OFFICER, DIRECTOR
CLIFFORD 
J. 
STOCKS 
DIRECTOR, EXECUTIVE OFFICER
KRISTINE 
 
SWIDEREK 
EXECUTIVE OFFICER
DAGUANG 
 
WANG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#